Vaxart Inc (VXRT)

$7.18 0.16 (2.18%)

19:59 EST VXRT Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap 51.27M

PE Ratio -1.31

EPS -5.500006

Volume (Avg. Vol.) 9.18M

Day's Range 6.95 - 7.74

52-Week Range 0.37 - 17.49

Dividend & Yield N/A (N/A)

VXRT Stock Predictions, Articles, and Vaxart Inc News

From InvestorPlace
From the Web

VXRT Stock News: Vaxart Shares Surge on Promising COVID-19 Vaccine News

By William White, InvestorPlace Writer Nov 12, 2020

Vaxart (VXRT) is getting a boost to VXRT stock on Thursday after releasing positive news concerning its vaccine for the novel coronavirus.

7 Biotech Penny Stocks Worth a Gamble

By Josh Enomoto, InvestorPlace Contributor Nov 11, 2020

With the pandemic drawing much attention toward biotech stocks, there are some interesting ideas among in the small-cap field, but only if you understand the severe risks involved.

Vaxart News: Why VXRT Stock Is Under Fire Today

By William White, InvestorPlace Writer Oct 19, 2020

Vaxart (VXRT) news for Monday isn't good as the company faces a federal investigation and lawsuits over its coronavirus claims.

The Small-Cap Tech Stocks Tripping My Moneyball ‘Buy’ Alerts

By Louis Navellier, Editor, Growth Investor Oct 2, 2020

Louis Navellier zeroes in on eventual stock winners, spots their key momentum levers, and allows smart folks to learn how to get positioned months or even years before the mainstream media finally catches on.

Trump Coronavirus News: Why the Market Is Sliding Today

By Sarah Smith, InvestorPlace Web Content Producer Oct 2, 2020

The market is sliding on today on Trump coronavirus news following confirmation that President Donald Trump tested positive.

3 Small-Cap Stocks To Buy For Large Cap Potential

By Ian Cooper Sep 24, 2020

It doesn’t matter who wins the U.S. election, because small cap stocks should outperform either way over renewed focus on domestic issues.

VXRT Stock: Vaxart Shoots Higher on Human Trial Approval

By Sarah Smith, InvestorPlace Web Content Producer Sep 14, 2020

Vaxart just announced it will begin enrolling participants in human trials of its coronavirus vaccine. VXRT stock is popping in response.

4 Catalysts Could Drive Inovio Pharmaceuticals Stock to Near-term Highs

By Ian Cooper Jul 22, 2020

Inovio Pharmaceuticals remains one of the most undervalued of the vaccine makers. Even after a 455% run higher, INO stock has plenty of upside fueled by plenty of catalysts.

5 Stocks to Buy That Are Holding Strong While Everything Else Crumbles

By Maya Sasson, Writer, TipRanks Mar 26, 2020

Unlike the broader market, these stocks to buy have managed to hold up strong amid the ongoing public health crisis.

Vaxart’s Flu Vaccine Looks Promising, But Its Future Is Uncertain

By Tom Taulli, InvestorPlace Writer & IPO Playbook Editor Oct 8, 2018

VXRT soared last week on favorable data. The company is developing a vaccine for the flu. And while the vaccine could be a game changer, VXRT stock still poses notable risks.